Literature DB >> 2903648

The role of adrenoceptors in circulatory and metabolic regulation.

P A Van Zwieten1.   

Abstract

This survey covers the classification and subdivisions of alpha- and beta-adrenoceptors, including alpha 1 and alpha 2, beta 1 and beta 2, and pre-and postsynaptic receptor subtypes, together with the distribution and functional relevance of the various adrenoceptor subtypes. The emphasis will be on their relevance in circulatory regulatory processes, especially those of the blood vessels. The alpha- and beta-adrenoceptor antagonists that interact with various receptor subtypes are briefly discussed. The control of alpha 2-adrenoceptors concerned with blood pressure regulation is an important target for centrally acting antihypertensive drugs (such as clonidine or alpha-methyldopa). Changes in adrenoceptor density, particularly the down-regulation of beta 1- adrenoceptors (but not beta 2), are found in congestive heart failure. However, the experimental findings about alpha-and beta-adrenoceptors in essential hypertension remain controversial. Finally, the influence of alpha- and beta-adrenoceptor antagonists on plasma lipids and carbohydrate metabolism is briefly reviewed. The changes found may be only partly explained on the basis of alpha- or beta-receptor blockade.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2903648     DOI: 10.1016/0002-8703(88)90128-7

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

1.  Adrenergic receptors coupled to adenylate cyclase in human cerebromicrovascular endothelium.

Authors:  F Bacic; R M McCarron; S Uematsu; M Spatz
Journal:  Metab Brain Dis       Date:  1992-09       Impact factor: 3.584

2.  Intrathecal clonidine in the neonatal rat: dose-dependent analgesia and evaluation of spinal apoptosis and toxicity.

Authors:  Suellen M Walker; Marjorie Grafe; Tony L Yaksh
Journal:  Anesth Analg       Date:  2012-03-30       Impact factor: 5.108

Review 3.  Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular disease.

Authors:  R J Milne; M M Buckley
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

4.  Upregulation of the alpha1-adrenoceptor-induced phosphoinositide and inotropic response in hypothyroid rat heart.

Authors:  Shahrzad Jalali; Melanie Durston; Vincenzo Panagia; Nasrin Mesaeli
Journal:  Mol Cell Biochem       Date:  2006-02       Impact factor: 3.396

5.  Changes in the haemodynamics of large arteries induced by single doses of nicardipine, enalapril, atenolol and urapidil.

Authors:  P Pancera; E Arosio; F Priante; M Ribul; M Zannoni; G Talamini; A Lechi
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 6.  Adverse reactions with beta-adrenoceptor blocking drugs. An update.

Authors:  R V Lewis; C Lofthouse
Journal:  Drug Saf       Date:  1993-10       Impact factor: 5.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.